Laura Appleton

Mrs. Laura Appleton

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2017 in Journal of Cystic Fibrosis
Verified
Journal Article
Closed access
MGMillie Garg
Millie Garg
Steven LeachSteven Leach
Steven Leach
MCMichael J. Coffey
Michael J. Coffey
TKTamarah Katz
Tamarah Katz
RSRoxanne Strachan
Roxanne Strachan
KOKeith Ooi
Keith Ooi

22 January 2019 in World Journal of Clinical Pediatrics
Verified
Journal Article
Open access
TRTarah Rigterink
Tarah Rigterink
LALaura Appleton
Laura Appleton
Andrew DayAndrew Day
Andrew Day
Vitamin D therapy in children with inflammatory bowel disease: A systematic review

1 February 2018 in Journal of Pediatric Gastroenterology and Nutrition
Verified
Journal Article
Closed access
PDF file
RLRobert N. Lopez
Robert N. Lopez
LALaura Appleton
Laura Appleton
RGRichard B. Gearry
Richard B. Gearry
ADAndrew S. Day
Andrew S. Day

1 August 2017 in Inflammatory Bowel Diseases
Verified
Journal Article
Closed access
PDF file
RLRobert N. Lopez
Robert N. Lopez
HEHelen M. Evans
Helen M. Evans
LALaura Appleton
Laura Appleton
JBJonathan Bishop
Jonathan Bishop
SCSimon Chin
Simon Chin
ADAndrew S. Day
Andrew S. Day
The incidence of pediatric inflammatory bowel disease (IBD) around the world is increasing. However, there is a scarcity of data on the epidemiology of pediatric IBD in the Southern Hemisphere. This study aimed to document the point prevalence of pediatric IBD in New Zealand on June 30, 2015. All patients in New Zealand, under 16 years of age, with a diagnosis of IBD on June 30, 2015 were identified. Demographic and disease phenotypic details were collected and entered into a secure database. Age-specific population data for New Zealand were obtained and national and regional prevalence rates were calculated. The point prevalence of pediatric IBD, Crohn's disease, ulcerative colitis, and inflammatory bowel disease unclassified in New Zealand on June 30, 2015 was (95% confidence intervals) 21.7 (18.9–24.8), 16.5 (14.0–19.2), 3.3 (2.2–4.6), and 1.9 (1.2–3.0) per 100,000 children, respectively. There was a striking disparity between the prevalence rates in the North and South Islands. The point prevalence of pediatric IBD in New Zealand represents the first-ever national, population-based prevalence rates of pediatric IBD published. Results from the Paediatric IBD in New Zealand (PINZ) study are also the first to show markedly higher prevalence rates of IBD in the southern part of a country compared with its northern counterpart. Ongoing prospective ascertainment of the incidence of pediatric IBD is required.

1 May 2018 in Journal of Pediatric Gastroenterology and Nutrition
Verified
Journal Article
Closed access
PDF file
RLRobert N. Lopez
Robert N. Lopez
HEHelen M. Evans
Helen M. Evans
LALaura Appleton
Laura Appleton
JBJonathan Bishop
Jonathan Bishop
SCSimon Chin
Simon Chin
ADAndrew S. Day
Andrew S. Day

6 November 2019 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
LALaura Appleton
Laura Appleton
Andrew DayAndrew Day
Andrew Day
We read with interest the article by Ng et al